Simplex Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,600
Closed -$1K 11555
2022
Q1
$1K Sell
2,600
-7,200
-73% -$6.11K ﹤0.01% 10220
2021
Q4
$12K Sell
9,800
-73,100
-88% -$130K ﹤0.01% 8903
2021
Q3
$223K Hold
82,900
﹤0.01% 5428
2021
Q2
$226K Buy
82,900
+82,543
+23,121% +$205K ﹤0.01% 5497
2021
Q1
$93K Sell
357
-624
-64% -$1.76K ﹤0.01% 5861
2020
Q4
$271K Buy
981
+607
+162% +$1.77K ﹤0.01% 4219
2020
Q3
$171K Buy
374
+208
+125% +$687 ﹤0.01% 4310
2020
Q2
$45K Sell
166
-15
-8% -$48 ﹤0.01% 5597
2020
Q1
$43K Sell
181
-123
-40% -$444 ﹤0.01% 5300
2019
Q4
$154K Hold
304
﹤0.01% 4039
2019
Q3
$196K Sell
304
-848
-74% -$5.85K ﹤0.01% 3584
2019
Q2
$717K Buy
1,152
+1,108
+2,518% +$8.44K ﹤0.01% 2235
2019
Q1
$47K Buy
44
+32
+267% +$319 ﹤0.01% 5060
2018
Q4
$9K Sell
12
-11
-48% -$159 ﹤0.01% 5934
2018
Q3
$45K Sell
23
-95
-81% -$1.73K ﹤0.01% 5273
2018
Q2
$213K Buy
118
+99
+521% +$1.46K ﹤0.01% 3412
2018
Q1
$22K Sell
19
-13
-41% -$209 ﹤0.01% 3280
2017
Q4
$73K Sell
32
-138
-81% -$6.19K ﹤0.01% 2081
2017
Q3
$415K Buy
170
+70
+70% +$11.8K 0.02% 767
2017
Q2
$129K Buy
100
+16
+19% +$2.81K 0.01% 1549
2017
Q1
$158K Buy
84
+59
+236% +$6.18K 0.01% 1397
2016
Q4
$71K Buy
25
+23
+1,150% +$2.42K ﹤0.01% 1814
2016
Q3
$1K Buy
+2
New +$240 ﹤0.01% 5509
2016
Q1
Sell
-8
Closed -$7K 6451
2015
Q4
$7K Sell
8
-24
-75% -$3.12K ﹤0.01% 3662
2015
Q3
$108K Buy
+32
New +$3.75K 0.01% 1358

Other funds holding SIOX

Simplex Trading's SIOX Position: Q1 2023 in Review

Simplex Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 132 shares — an estimated $56 sold.

Simplex Trading first reported a position in SIOX in Q3 2015 and held it in 25 quarters. The position peaked at $749K in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Simplex Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 132 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $56.
  • Simplex Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 25 quarters.
  • Simplex Trading's Sio Gene Therapies Inc. Common Stock position peaked at $749K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.